The Undersea Medicine program develops science and technology solutions aimed at optimizing submariner and diver performance and enhancing the flexibility, efficiency and safety of undersea warfighter missions. An important result of this program is to decrease the logistical burden of medical operations for both diving and submarines and enable safe submarine escape and rescue operations. Solutions should extend the warfighter's reach and allow freedom of action in the water column, thermal extremes and in contaminated water. Solutions from diverse areas such as biological, computer and behavioral sciences are encouraged, with the objective of developing improved methods, models, treatments and devices for understanding, preventing or mitigating adverse health effects (including psychological) that negatively impact submarine and diving operations.
Program interests currently include, but are not limited to, understanding the pathology and etiology of decompression illnesses (i.e., decompression sickness (DCS) and arterial/venous gas embolism (AGE/VGE)), hyperbaric oxygen toxicity, nitrogen narcosis and high-pressure nervous syndrome; nonrecompressive prevention and treatment of DCI; management and mitigation of hyperbaric oxygen toxicity; identifying potential long-term health effects of diving and exposure to submarine environment; safe diving in contaminated water; interventions against underwater sound/blast effects; improvements in submarine crew and diver performance; improved trauma management in submarine special forces operations.
Long Range Broad Agency Announcement (BAA) for Navy and Marine Corps Science and Technology BAA N00014-16-R-BA01
N00014-16-R-BA001.pdf (PDF - 463.41 KB)
Amendment 0001 (PDF - 462.24 KB)
Amendment 0002 (PDF - 370.21 KB)
BAA N00014-16-R-BA01 Amendment 0003 (PDF - 369.79 KB)
Published: October 1, 2015 12:15 PM EST | Full Proposals will be accepted until September 30, 2016 05:00 PM EST